Loading
Everything OnCo dates to 1979: 9 entries, 3 landmarks, 2 journals founded, 1 approval and 1 company founded. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.
9 dated entries in OnCo fall in 1979: 3 landmarks, 2 journals founded, 1 approval, 1 company founded, 1 paper listed on a person's page and 1 technology.
Of those, 9 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.
Everything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.
The approvals rows on treatment records: region, year and indication.
Remission induction in acute non-lymphocytic leukaemia (adults) and acute lymphocytic leukaemia (adults and children), in combination
The history entries editors wrote on cancer records: the dated turning points of each disease.
Cancer of unknown primary (CUP). Recognition of the extragonadal germ cell subset.
Gestational trophoblastic neoplasia
Osteosarcoma
The since year on technology records: first use in humans or first approval, as the record states it.
First use in humans or first approval, as the technology record states it.
The founded year on company records.
Lund
The founded year on journal records.
Springer Nature
Chinese Medical Association
The selected publications each biography lists, which is a reading of that person rather than a reading of the year.
International Journal of Radiation Oncology*Biology*Physics